Mary Ann Lumiqued

Mary Ann Lumiqued is the Vice President Program Management at Tubulis GmbH, where Mary Ann is responsible for advancing the development plans of the company's emerging antibody drug conjugate pipeline. Prior to this role, Mary Ann served as the Global Medical Affairs - Head of Project Strategy and Operations at MorphoSys, and Director of Program Leader Proprietary Development. With a background in project management, Mary Ann has also held roles at companies such as Acorda Therapeutics, Ipsen, OXiGENE, Anesiva, and Corgentech Inc. Mary Ann holds a B.S. in Animal Physiology and Neuroscience from UC San Diego and a Professional Award in Biotechnology Management with an Emphasis in Project and Program Management from the University of California, Santa Cruz.